Pharma · Private company
Sandoz
Track this companyFree. Adds Sandoz to your Dealase workspace and tells you when its record changes.
Clinical trials121 recruiting or active
Pipeline programs21From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline21
- CYB704Phase 3 · Relapsing Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- EU-Prolia (EU-authorized Prolia®)Phase 3 · Postmenopausal Women With OsteoporosisClinicalTrials.gov · fetched Nov 12, 2026
- Eylea EU (40 mg/mL)Phase 3 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- Fluticasone furoate (Veramyst®) 27.5 mcg/actuation nasal sprayPhase 3 · Rhinitis, Allergic, SeasonalClinicalTrials.gov · fetched Nov 12, 2026
- Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals)Phase 3 · Rhinitis, Allergic, SeasonalClinicalTrials.gov · fetched Nov 12, 2026
- GME751Phase 3 · Metastatic NSCLCClinicalTrials.gov · fetched Nov 12, 2026
- GP2411Phase 3 · Postmenopausal Women With OsteoporosisClinicalTrials.gov · fetched Nov 12, 2026
- Keytruda-EUPhase 3 · Metastatic NSCLCClinicalTrials.gov · fetched Nov 12, 2026
- Mometasone furoate (Nasonex®) 50 mcg/actuation nasal sprayPhase 3 · Rhinitis, Allergic, SeasonalClinicalTrials.gov · fetched Nov 12, 2026
- Mometasone furoate 50 mcg/actuation nasal spray (Lek Pharmaceuticals)Phase 3 · Rhinitis, Allergic, SeasonalClinicalTrials.gov · fetched Nov 12, 2026
- Ocrevus-EUPhase 3 · Relapsing Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Ocrevus-USPhase 3 · Relapsing Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Prefilled Syringe (PFS)Phase 3 · Neovascular Age-related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
- SOK583A1Phase 3 · Neovascular Age-related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
- SOK583A1 (40 mg/mL)Phase 3 · Neovascular Age-related Macular Degeneration (nAMD)ClinicalTrials.gov · fetched Nov 12, 2026
- SOK583A1 (40 mg/mL)Phase 3 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- Ferric carboxymaltosePhase 1 · Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- GME751Phase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Keytruda - EUPhase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Keytruda - USPhase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- AmLactin® Rapid ReliefDry SkinClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple SclerosisPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 10, 2025ClinicalTrials.gov NCT06847724 · fetched Nov 12, 2026
- A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III MelanomaPHASE1 · COMPLETED · started May 15, 2024ClinicalTrials.gov NCT06153238 · fetched Nov 12, 2026
- A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)PHASE3 · COMPLETED · started Apr 29, 2024ClinicalTrials.gov NCT06159790 · fetched Nov 12, 2026
- Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial KitPHASE3 · COMPLETED · started May 16, 2022ClinicalTrials.gov NCT05282004 · fetched Nov 12, 2026
- Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled SyringePHASE3 · COMPLETED · started Mar 11, 2022ClinicalTrials.gov NCT05161806 · fetched Nov 12, 2026
- Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular DegenerationPHASE3 · COMPLETED · started May 12, 2021ClinicalTrials.gov NCT04864834 · fetched Nov 12, 2026
- Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal OsteoporosisPHASE3 · COMPLETED · started Jul 2, 2019ClinicalTrials.gov NCT03974100 · fetched Nov 12, 2026
- This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter CosmeticNA · COMPLETED · started Mar 26, 2019ClinicalTrials.gov NCT04085809 · fetched Nov 12, 2026
- A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency AnemiaPHASE1 · COMPLETED · started Nov 29, 2017ClinicalTrials.gov NCT03399084 · fetched Nov 12, 2026
- The Mycophenolate Pregnancy RegistryCOMPLETED · started Nov 20, 2012ClinicalTrials.gov NCT01733082 · fetched Nov 12, 2026
- A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic RhinitisPHASE3 · COMPLETED · started Dec 27, 2010ClinicalTrials.gov NCT01279057 · fetched Nov 12, 2026
- A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic RhinitisPHASE3 · COMPLETED · started Dec 2, 2009ClinicalTrials.gov NCT01038427 · fetched Nov 12, 2026